Background--Endothelial cell responses during inflammation are heterogeneous and key for selectivity in how leukocytes hone in on specific sites and why vascular diseases are highly bed specific. However, mechanisms for this specificity remain unclear.
unique patterns of inflammation-induced changes in protein expression and leukocyte recruitment between different endothelial cells. [5] [6] [7] [8] [9] Moreover, specific vascular beds are more susceptible to the development of certain inflammatory diseases, 10 underscoring the broad diversity of the endothelium and its role in conferring selectivity and sensitivity to different pathogenic stimuli. Although collectively these studies have confirmed the innate heterogeneity of endothelial cells, they have severely suffered from 2 major shortcomings: limited end-point analysis and lack of coverage of representative beds. That is, they often compare cells from venous versus microvascular or arterial versus venous origins, but none of these studies have examined endothelial cells from large (aorta), medium (carotid and subclavian), and small (coronary) arteries versus cells of venous origin. Further, these studies have incorporated cells from multiple donors, which can introduce uncontrolled genetic and epigenetic factors that will influence results. With respect to end points assessed to evaluate heterogeneity of endothelial responses to inflammatory stimuli, studies have focused on early signaling events such as activation of MAPKs 11 and transcription factors (NF-jB and KLF2) 12, 13 or on more chronic responses related to protein adhesion molecule expression (eg, intracellular adhesion molecule-1 [ICAM-1] and vascular cell adhesion molecule-1 [VCAM-1]). 7, 12, 14 Importantly, however, adhesion molecules are heavily N-glycosylated, which is critical for function. Protein glycosylation is an enzyme-driven co-/posttranslation modification that occurs in the endoplasmic reticulum (ER) and Golgi, whereby saccharides are added to the amide residue of asparagine (N-glycosylation) or the hydroxyl group of serine or threonine (O-glycosylation). 15, 16 It has been established that innate differences in surface carbohydrate patterns exists across vascular endothelium in vivo 17, 18 which is further modified during inflammation and disease. 14, [19] [20] [21] Moreover, it is now evident that endothelial cell expressed carbohydrates are involved in leukocyte trafficking, with these sugars providing a "zip code" to allow specific leukocyte subsets to migrate into specific tissues in response to specific stimuli. 19, [22] [23] [24] [25] For example, our recent studies demonstrate a role for endothelial high mannose N-glycans in monocyte rolling/adhesion and suggest that N-glycosylation per se is regulated by inflammatory stimuli, by mechanisms that are distinct from those that affect adhesion molecule protein expression. 22 This suggests that in addition to upregulation of protein adhesion molecule expression, N-glycosylation of these adhesion molecules may also be controlled during inflammation. However, no comparison of surface N-glycan profiles across cultured primary endothelial cells under basal and stimulated conditions has been conducted. To test the hypothesis that endothelial N-glycans are dynamically regulated during inflammation and in a vascular bed-specific manner to regulate leukocyte interactions, we examined the response of human vascular endothelial cells from 5 distinct arterial vascular beds isolated from a single donor to the commonly used pro-inflammatory stimuli tumor necrosis factor-a (TNF-a), lipopolysaccharide (LPS), and interleukin-1b (IL-1b). In addition, responses of human umbilical vein and pulmonary microvascular endothelial cells (from different donors) were also examined. Acute (ERK1/2 and NF-jB [p65] phosphorylation) and chronic (ICAM-1 and VCAM-1 expression) readouts of inflammatory signaling responses, surface N-glycan expression and monocyte adhesion under basal and activated conditions were compared within and across all cell lines. The results indicated significant bed-dependent responses to stimulation and collectively highlighted the importance of choosing the appropriate cell model for understanding disease mechanisms as well as the need to confirm new findings in multiple vascular beds.
Materials
Human umbilical vein endothelial cells (HUVECs) and human pulmonary microvascular endothelial cells (HPmvECs) were purchased from Lonza Corporation and were isolated from a Hispanic female and white male, respectively (per vendor specifications). Human aortic (HAEC), carotid artery (CtAEC), coronary artery (CoAEC), subclavian artery (SCEC), and brachiocephalic artery (BCEC) endothelial cells were obtained from a 51-year-old white man (Cell Applications, San Diego, CA). MCDB-131, RPMI 1640, fetal bovine serum (FBS) trypsin-EDTA, and CellTracker Green were purchased from Invitrogen (Carlsbad, CA). All other reagents were from Sigma-Aldrich (St. Louis, MO) unless otherwise noted.
Cell Culture and Treatments
Endothelial cells were propagated on gelatin-coated dishes in MCDB-131 containing 10% heat-inactivated fetal bovine serum (FBS), 25 lg/mL endothelial cell growth supplement (BD Biosciences), 30 lg/mL heparin, and penicillin (100 U/ mL)/streptomycin (100 lg/mL). For experiments, cells were serum-starved for 2 hours (0-to 1-hour treatments) or transitioned to MCDB-131 containing 1% HI-FBS without ECGS (4-to 24-hour treatments) and were stimulated with 10 ng/mL TNF-a, 2.5 ng/mL IL-1b, or 100 ng/mL LPS for the indicated times. For acute and chronic protein expression, cells were used at passage 4 or 5. For N-glycan analysis, monocyte adhesion cells were used as passage 5 or 6. a-Mannosidase activity assays were performed between passages 4 and 7. Because endothelial cell aging in culture can be associated with changes in phenotype, adhesion molecule expression, and sensitivity to cytokines, [26] [27] [28] we ensured that cell passage were identical when comparing like parameters. Cells were seeded at 5910 3 cells/cm 2 and used 1-day postconfluency. THP-1 monocyte cells were maintained in RPMI 1640 containing 10% heat-inactivated FBS, penicillin (100 U/mL)/streptomycin (100 ng/mL), and 2 mmol/L betamercaptoethanol. For adhesion experiments THP-1 cells were labeled with CellTracker Green (1 lmol/L) for 15 minutes at 37°C.
Monocyte Adhesion Assay
Static adhesion assays were performed as previously described. 22 Briefly, endothelial cells were grown to confluence in 48-well plates and treated as described. Surface ELISA Cells were treated as described, washed in PBS, and fixed in 4% paraformaldehyde for 10 minutes. Fixed cells were blocked in TBS containing 5% goat serum and 5% BSA for 30 minutes and incubated in the same buffer containing mouse anti-ICAM-1 (ab2213; Abcam, Danvers, MA) and VCAM-1 for 1 hour at room temperature. After washing, cells were incubated with goat anti-mouse Alexa Fluor 488 (Invitrogen) for 30 minutes at room temperature in TBS containing 5% goat serum. After exhaustive washing in TBS, fluorescence was measured as above.
Lectin Stain
Surface staining of carbohydrates was performed as previously described. 19 Cells were washed in ice-cold PBS containing MgCl and CaCl (1 mmol/L each) and kept in the same buffer for 10 minutes to abolish endocytosis. Cells were labeled with fluorescein-conjugated lectins (ConA, LCA, SNA, PHA-L; Vector Labs) for 10 minutes on ice before exhaustive washing in PBS and detection of fluorescence as above.
a-Mannosidase Activity Assay
Cells were treated as described and lysed (PBS, 1% Triton X-100) for 10 minutes on ice before clarification at 10,000g for 10 minutes. 
Western Blotting
Protein samples were collected in SDS-PAGE sample buffer, boiled for 10 minutes, resolved on 4% to 15% TGX gels, and transferred to PVDF membranes (BioRad, Hercules, CA). Blots were blocked with 5% milk in TBS + 0.1% Tween-20 (TBST) and incubated overnight at 4°C with antibodies against ICAM-1 (#4915), ERK (#4695), p-ERK (T202,Y204; #4370; Cell Signaling Technologies; Danvers, MA), p65 (sc372), p-p65 (S536; sc33020), VCAM-1 (sc-8304; Santa Cruz Biotechnology, Santa Cruz, CA), and b-actin (ab123020; Abcam). Blots were washed in TBST, incubated with species-appropriate HRP-conjugated secondary antibody (Pierce), and washed again in TBST, and signals were detected using ECL (PerkinElmer) and x-ray film (ThermoFisher).
Statistics
All experiments were conducted a minimum of 3 times (interexperimental replicates), with 3 replicates performed within each (intraexperimental) experiment. Significant differences were calculated using GraphPad Figure 3A through 3D shows that there were no differences in the basal expression of TNFR1 (TNF-a receptor responsible for mediating pro-inflammatory signaling of this cytokine) or IL1-R1 (IL-1b receptor). Moreover, no correlation was observed between the relative expression of TNFR1 or IL1-R1 and the degree of ERK ( Figure 3E through 3F) or p65 activation ( Figure 3H through 3I). For TLR4, however, significant differences in basal expression were observed, being relatively lower in CoAECs, HAECs, HUVECs, and PmvECs ( Figure 3D ). Interestingly, significant and positive correlations between TLR4 expression and p65 phosphorylation were observed but not for ERK phosphorylation ( Figure 3G and 3J) . Similarly, any differences in the basal expression ratios of p-ERK:ERK and p-p65:p65 could influence the degree of activation observed after the addition of inflammatory stimuli. Figure 4 shows that basal p-ERK:ERK ratios were highest in CtAECs. Relative analysis of p-p65:p65 was not possible as the phosphorylated form was not detectable basally in BCECs, CtAECs, and SCECs (not shown). Figure 4B through 4D shows correlations between basal pERK:ERK expression and the induction of ERK phosphorylation by TNF-a, IL-1b, and LPS, respectively. No correlations were observed. All together, these data further illustrate the heterogeneity between endothelial cells and indicate that neither the basal expression of the respective receptors for TNF-a, LPS, or IL1b nor
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To assess if more chronic signaling responses were also distinct, cells were exposed to TNF-a, LPS, or IL1b for 0, 4, 12, or 24 hours, and the expression of ICAM-1 and VCAM-1 was determined. As seen in Figure 5 , TNF-a and IL-1b induced ICAM-1 and VCAM-1 expression in all cells. Notable observations include distinct time-dependent changes in ICAM-1 versus VCAM-1, minimal induction of adhesion molecule expression in HAECs by LPS, and a relatively lower degree of adhesion molecule expression in PmvECs compared with other cells. To better understand how the level of expression differed between cell lines, the same lysates from Figure 5 (4-and 24-hour treatments) were run side by side for a direct comparison. Figure 6 shows that the expression of adhesion molecules was highly diverse, with CoAECs and HUVECs generally having the highest expression with all stimuli.
To participate in leukocyte adhesion, ICAM-1 and VCAM-1 must be positioned on the surface of endothelial cells so that they can engage with their integrin ligands. Therefore, to better assess functional implications, ICAM-1 and VCAM-1 expression was measured on the cell surface using a surface ELISA in unpermeabilized cells. As seen in Figure 7 , there was a time-dependent induction of ICAM-1 in all cell types with all stimuli. In contrast, VCAM-1 expression was maximal in all cases by 4 hours. Note that only TNF-a induced significant VCAM-1 surface expression in HUVECs, whereas none of the stimuli significantly increased VCAM-1 levels in SCECs. A comparison of the expression of ICAM-1 and VCAM-1 across the cell lines can be found in Figure 8 and highlights that ICAM-1 and VCAM levels were generally highest in CoAECs and HUVECs with all stimulations. Collectively, these data show that whole-cell lysate measurements of ICAM-1 or VCAM-1 did not necessarily correlate with surface expression and demonstrate significant vascular bed specificity in how TNF-a, LPS, and IL-1b mediate upregulation of these adhesion molecules.
Heterogeneity in Cell Surface N-Glycan Content
Carbohydrate modifications of endothelial adhesion molecules (both O-and N-glycans) provide important ligands for leukocyte receptors. Our recent studies implicated a role for N-glycan-linked high-mannose epitopes on aortic endothelium in recruiting monocytes. 19, 22 Carbohydrate profiles on the surface display vascular bed specificity under basal conditions, but little is known about whether this changes during inflammation also in a bed-dependent manner. Figure 9 shows surface staining of different endothelial cells under basal conditions with a panel of lectins ( Table 1) that collectively recognize high mannose, hybrid, and complex N-glycans, thereby providing broad coverage of all major N-glycan types. As seen in Figure 9 , there was no difference in the basal levels of SNA or PHA-L binding across the cell types, but ConA binding was higher in CtAECs and CoAECs Previously we demonstrated that TNF-a-dependent stimulation of high mannose/hybrid structures on the HAEC surface was associated with decreased a-mannosidase (a-MAN) activity. 7 N-glycan maturation occurs in a stepwise process, whereby mannose residues are trimmed in the ER and Golgi by a family of a-mannosidases. The resultant platforms allow for subsequent maturation into complex N-glycan structures. 15 Inhibition of a-MAN activity therefore results in the accumulation of hypoglycosylated high-mannose N-glycans. Numerous studies have now shown that limiting N-glycan branching promotes inflammatory disease development. [29] [30] [31] [32] [33] We hypothesized that distinct sensitivity of a-MAN during inflammation may provide a mechanism to explain distinct responses of endothelial cells from different vascular beds. Figure 11A shows that basal a-MAN activity varied 3-fold among the cell types studied, with activity being highest in HUVECs. Activity in BCECs and CtAECs was also greater compared with CoAECs, HAECs, PmvECs, and SCECs. Figure 11B shows that TNF-a significantly decreased a-MAN activity in HAECs and HUVECs, significantly increased it in PmvECs and SCECs, and had no effect in BCECs, CtAECs, or CoAECs. TNF-a-dependent decreased a-MAN activity in HUVECs and HAECs correlated with the increased ConA binding observed in these cells ( Table 2 ), suggesting that this family of enzymes is critical regulators of endothelial N-glycan processing and, importantly, is distinctly regulated in different vascular beds.
Heterogeneous Stimulation of Monocyte Adhesion
Functional insights into altered basal and stimulated N-glycosylation profiles were determined by measuring THP-1 monocyte adhesion to endothelial cells under basal and activated conditions. Figure 12 shows a striking diversity in basal adhesiveness, with CoAECs and SCECs displaying elevated adhesion compared with other cells tested. After stimulation, TNF-a significantly increased adhesion in all cells except BCECs, and only in CtAECs and SCECs was there temporal activation of adhesion. LPS stimulated adhesion in all cells although not at all times, as it failed to increase adhesion in BCECs at 4 hours and SCECs at 24 hours. Finally, IL-1b increased adhesion in all cells at all times except for SCECs, in which it had no effect. Collectively, these data demonstrate bed-and stimulus-specific differences in monocyte adhesion.
Discussion
In the current work we have examined the heterogeneity of vascular endothelial cells under basal and stimulated conditions to better understand the dynamic nature of inflammatory responses seen throughout the vasculature. We used BCECs, HAECs, CtAECs, CoAECs, and SCECs isolated from a single donor to overcome potential genetic/ epigenetic effects that are likely factors when comparing cells from multiple donors. We also tested HUVECs and PmvECs that were from different donors to provide a comparison with commonly used vascular beds. We acknowledge the limitations in this approach, as insights gained may be donor
4 hours 24 hours specific and also note the potential for heterogeneity introduced because of underlying diseases present within defined regions of any part of the vasculature. That said, the large majority of studies employing endothelial cells do not describe the number of donors used (most likely 1 and 2) or the basal health status of the donor that the cells were derived from. With this mind, we opted to use cells from only 1 donor because our primary goal was to assess the vascular bed of origin on arterial endothelial cell responses to inflammatory stimuli. Our data show that broad heterogeneity exists in the intrinsic response to stimuli in terms of signaling pathway activation (Figure 1) , extent of adhesion molecule expression (Figures 5-8 showed the ability of LPS to activate NF-jB in all cells tested, despite profound differences in adhesion molecule expression and cytokine production, demonstrating that there is an uncoupling of endothelial cell activation and proadhesive response. However, this is not surprising given that the cells were from 30 separate donors and included not only uncontrolled variables such as race and age or genetic/ epigenetic variation in receptor expression (TLR4) but also lifestyle factors such as tobacco and alcohol use. In the current work, LPS potently induced ICAM-1/VCAM-1 ( Figures 6 and 7 ) expression in CoAECs and HUVECs, but to a much lesser extent in other cells, this despite CoAECs and HUVECs having significantly lower TLR4 expression than other cells tested (BCECs, CtAECs, SCECs), indicating that this selective sensitivity to LPS was not regulated at the receptor level. We do note, however, that p65 activation was proportional to the basal level of TLR4 expression. Given that the endothelial cells were from a single donor, environmental factors and underlying donor-specific variations can be ruled out, and thus a clear conclusion that there are vascular bedspecific differences in LPS signaling can be drawn. Although this is certainly understood given the body of literature cited above, this finding was unexpected in the current work, as the cells were all of arterial origin and from a single donor. It is also striking to note that cells from CoAECs routinely displayed the highest adhesion molecule expression ( Figure 1 ) and increased levels of basal hypoglycosylated N-glycans ( Figure 9 ) and monocyte adhesion ( Figure 12 ). It is possible that the donor had underlying inflammation in the coronary artery and that this led to these findings. However, that does not change the finding that these cells, when compared with the other arterial beds from that donor, displayed elevated activation and highlights the importance of choosing the proper bed for experimentation as well as the limitation in data interpretation that can come from examining only 1 vascular bed. This underscores that, although cumbersome for researchers, novel findings need to be confirmed in Our data also demonstrate that although profound differences in endothelial cell activation and adhesion molecule expression exist, so do surface N-glycan content and N-glycan processing potential ( Figures 10 and 11 and Table 1 ). The latter is interesting because regulation of protein expression is controlled by the genetic code, but N-glycan-dependent posttranslation modification is largely controlled by the relative activity of N-glycan processing enzymes and carbohydrate substrate availability. We suggest that modulation of a-MAN activities is a critical and novel mechanism that couples canonical inflammation-dependent activation of NF-jB and adhesion molecule expression with ensuring that the N-glycoforms of these proteins are appropriately formed and, moreover, that this occurs in a vascular bed-specific manner. From a functional perspective, N-glycosylation is typically thought to ensure proteins are folded and trafficked to membranes for surface expression or secretion (eg, for E-and L-selectin [35] [36] [37] ). However, mounting evidence suggests that endothelial cell N-glycans are also critical mediators of leukocyte trafficking. 1, 19, 22 In terms of endothelial adhesion molecules known to participate in leukocyte recruitment, the glycosylation status of ICAM-1, 38,39 VCAM-1, 23 and PECAM-1 40 has been shown to affect functions pertaining to leukocyte recruitment. Interestingly, in the case of each of the proteins in which N-glycosylation is known to play a role in function, less complex N-glycans (hypoglycosylated N-glycans) appear to promote leukocyte trafficking. 1, 9, 40 In support of this conclusion, CoAECs displayed elevated basal levels of hypoglycosylated N-glycans ( Figure 9 ) and also showed the highest level of basal THP-1 binding ( Figure 12 ). As to which adhesion molecules could possibly carry these N-glycans, 45 and implicates a potential role of ICAM-1 mannose residues in leukocyte interactions. Another possible candidate is VCAM-1, as removal of sialic acid increases leukocyte trafficking, but this phenomenon was difficult to explain, as no N-glycan sites are found in proximity to the VLA-4 binding domain. 23 This gap has recently been clarified by studies demonstrating that galectin-3 can bind to VCAM-1 and support leukocyte adhesion. 24, 25 With PECAM-1, a-2,6-sialic acid has been reported to be critical for homodimerization and associated antiapoptotic signaling. 40 Whether ICAM-1, PECAM-1, VCAM-1, or any of the other proteins mentioned exist in hypoglycosylated forms or in different N-glycoforms in different vascular beds requires additional investigation. It should be noted that the glycosylation state of adhesion molecules is known to be directly influenced by the cell in which they are produced, [46] [47] [48] [49] so the concept of regional N-glycoforms of proteins is intriguing.
In fact, the concept that regional changes in endothelial glycosylation could regulate immune cell trafficking by creating a "zip code" is not new. 21 In this scenario, the adhesion molecule protein acts as a molecular scaffold that carries the glycan, and only when found together can proper receptor-ligand interactions occur. This concept has been well explored in leukocytes in which certain proteins such as PSGL-1 carry sialyl-Lewis x (sLe x ) epitopes that are ligands for endothelial selectins. 50 However, not all PSGL-1 proteins contain sLe x , and many proteins that do contain sLe x are not ligands for endothelial selectins. This clearly demonstrates that to support maximal leukocyte adhesion, the proper combination of protein adhesion molecule and N-glycan must be present. 37 We hypothesize that expression of specific adhesion molecule glycoforms with distinct functions or selective interactions with leukocyte subsets will be vascular bed dependent. Other notable findings in the current work include differences between VCAM-1 and ICAM-1 expression within a cell type and the lack of any direct correlation between these adhesion molecules when measured in whole-cell lysates by Western blotting compared with surface expression. Expression of both VCAM-1 and ICAM-1 occurs via NF-jB-dependent processes. However, clear cell-type and inflammatory stressdependent differences in how these adhesion molecules are induced were evident. Specifically, both ICAM-1 and VCAM-1 displayed time-dependent increases in whole-cell lysates, which was largely correlated with temporal changes for ICAM-1 on the cell surface. In contrast, VCAM-1 surface expression was maximal at 4 hours and was not induced at all in SCECs, despite significant increases in expression by all cytokines tested measured by Western blotting. Whether this reflects differential protein turnover rates or inefficiency of membrane expression of newly transcribed proteins is unclear. However, because the surface-expressed protein is the functional one, these data suggest that surface expression needs to complement any whole-cell measurements when functional implications for leukocyte adhesion are being discerned. This is underscored by the discussion above highlighting the potential role for specific N-glycoforms in imparting functional selectivity. In summary, the work presented highlights the complex heterogeneity that exists across endothelial cells from different vascular beds. Characteristic profiles of activation, adhesion molecule expression, and surface carbohydrate content lead to unique patterns of monocyte adhesion. Further research is required, especially in vivo, to determine how this heterogeneity contributes to leukocyte trafficking in inflammation and disease. 
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